2026 NPPES data General Practice Physician NPI 1881832152
Verify on CMS →

Analiese Medero-Gierbolini

General Practice Physician in Trujillo Alto, Puerto Rico.

This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 16,725 in General Practice Physician, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.

Federal data, no proprietary rating. We show these CMS records as-is - no composite score, no star rating, no editorial opinion layered on top.
Prescribing volume
384
Medicare Part D claims · 224 beneficiaries · General Practice Physician avg: 3K
Generic prescribing
96%
generic claims · 4% brand-name · higher generic rates reduce patient out-of-pocket costs
Compiled from official public sources by the PlainDoctor editorial team.

What the federal data shows

Analiese Medero-Gierbolini filed 384 Medicare Part D claims in 2023 as a General Practice Physician in Trujillo Alto, Puerto Rico, prescribing 96% generic.

384
Part D claims, 2023
96%
generic prescribing

Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.

Analiese Medero-Gierbolini's Medicare Part D volume vs every U.S. prescriber

Total Medicare Part D claims, 2023, across all CMS prescribers nationally

384 Top 43% higher than 57% of 1,370,886 prescribers

0–200: 670,926 prescribers (49%). Below this entry. 200–400: 182,923 prescribers (13%). This entry sits in this band. 400–600: 90,619 prescribers (7%). Above this entry. 600–800: 56,224 prescribers (4%). Above this entry. 800–1,000: 40,919 prescribers (3%). Above this entry. 1,000–1,200: 31,827 prescribers (2%). Above this entry. 1,200–1,400: 26,224 prescribers (2%). Above this entry. 1,400–1,600: 21,710 prescribers (2%). Above this entry. 1,600–1,800: 19,072 prescribers (1%). Above this entry. 1,800–2,000: 16,451 prescribers (1%). Above this entry. 2K+: 213,991 prescribers (16%). Above this entry. This provider 0 2K+ every Part D prescriber (claims/yr), bucketed by value

Each bar is a band; taller bars hold more prescribers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Medicare Part D Prescriber Public Use File · 2023

Board-eligible specialty (heuristic, not verified)

Analiese Medero-Gierbolini practices in an ABMS-board-eligible specialty but we don't have enough CMS-participation signals to confirm active board-certified status. Consult CertificationMatters.org (the official ABMS public lookup).

What does the federal data show about Analiese Medero-Gierbolini?

Quality data not reported

NPI registry status

Active

Issued 01/26/2009

NPI 1881832152

Primary specialty

General Practice Physician

Mid-sized

16,725 US NPIs in this specialty

Medicare Part D claims

384 87% vs specialty avg

2023 prescription claims

Specialty avg: 2,872

Specialty distribution in Puerto Rico

How General Practice Physician compares to other specialties among Puerto Rico providers

Puerto Rico providers
General Practice Physician - 10%General Practice Physician10%Student in an Organized Health Care Education/Training Program - 8.9%Student in an Organized Health Care Education/Training Program8.9%Pharmacist - 8%Pharmacist8%Pharmacy Technician - 5.1%Pharmacy Technician5.1%Clinical Psychologist - 4.7%Clinical Psychologist4.7%Clinical Social Worker - 4.2%Clinical Social Worker4.2%
Largest specialties in Puerto Rico (% of in-state providers)

Board certification

Not published by CMS

CMS does not publish a per-provider board-certification field in NPPES. PlainDoctor does not have a reliable per-specialty certification rate to show for General Practice Physician. Verify directly:

How MIPS and board certification work

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

Analiese Medero-Gierbolini appears in the CMS NPPES registry as a General Practice Physician provider at CARR. 175 KM 9.2 CAM. EDUVIGE RIVERA, Trujillo Alto, PR, 00976, with a listed phone of (787) 755-3003. NPI 1881832152 was issued on 01/26/2009.

Medicare Part D records for calendar year 2023 show 384 prescription claims written by this provider, covering 224 Medicare beneficiaries and totaling roughly $6K in drug spend, split 4% brand-name and 96% generic by claim count.

General Practice Physician is a mid-sized specialty nationwide, with 16,725 enrolled providers across 56 states and an average of 2,872 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline.

Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist, always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

CARR. 175 KM 9.2 CAM. EDUVIGE RIVERA
Trujillo Alto, PR 00976

Provider Details

NPI 1881832152
Specialty General Practice Physician
Gender Female
NPI Issued 01/26/2009

Brand vs generic prescribing mix · Generic-heavy

Analiese Medero-Gierbolini - brand share 4.0%
General Practice Physician average

4% brand-name claims vs 96% generic, on 384 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

384
Total Claims
$6K
Total Drug Cost
224
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
399
Total Day Supply
4,001
Brand vs Generic
4% brand / 96% generic
Brand Drug Cost
$2K
Generic Drug Cost
$3K
Antibiotic Claims
105

Patient Demographics

Average Patient Age
70.2 years
Avg HCC Risk Score
1.82
Gender Split
64% female / 36% male
Age Distribution
<65: 54, 65-74: 90, 75-84: 65, 85+: 15

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

What Analiese Medero-Gierbolini prescribes most

Top Medicare Part D drugs by claim count, 2023

claims
Source CMS Medicare Part D Prescriber Public Use File As of 2023
Drug Claims
Famotidine
42
Azithromycin
31
Prednisone
26
Amoxicillin-Clavulanate Potass
Amoxicillin/Potassium Clav
24
Fluticasone Propionate
24
Baclofen
17
Diclofenac Potassium
15
Ciprofloxacin Hcl
14
Levofloxacin
14
Meloxicam
14

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

General Practice Physician Overview

How Analiese Medero-Gierbolini fits within the General Practice Physician landscape nationally.

16,725
General Practice Physician Providers in US
56
States with General Practice Physician
2,872
Avg Claims per Provider

Analiese Medero-Gierbolini's 384 claims are below the specialty average of 2,872.

Nearby General Practice Physician Providers in Puerto Rico

Other clinicians with the same primary specialty enrolled in Puerto Rico, drawn from the same CMS NPPES roster as Medero-Gierbolini.

Compare General Practice Physician nationally: see state-by-state distribution →

Before you book an appointment

Use this federal record as your verification checklist, not as a recommendation.

  • Confirm the NPI record is current in the official CMS registry, providers update their own NPPES details, and moves can lag. Verify this NPI
  • Check the active license and any disciplinary history with the Puerto Rico medical board, federal registration is not a license check. Credential verification guide
  • Weigh a second option: compare this provider with a nearby General Practice Physician peer on Medicare volume and prescribing patterns. Compare providers

Medicare Part D and MIPS figures describe practice patterns in federal programs only, they are not quality ratings, and PlainDoctor does not rate, rank, or recommend providers.

Frequently Asked Questions

What is Analiese Medero-Gierbolini's specialty?
Analiese Medero-Gierbolini specializes in General Practice Physician and practices in Trujillo Alto, Puerto Rico.
How much does Analiese Medero-Gierbolini prescribe under Medicare Part D?
In 2023, Analiese Medero-Gierbolini wrote 384 Medicare Part D claims totaling $6K in drug costs for 224 beneficiaries.
Where is Analiese Medero-Gierbolini located?
Analiese Medero-Gierbolini is located at CARR. 175 KM 9.2 CAM. EDUVIGE RIVERA, Trujillo Alto, PR, 00976. Phone: (787) 755-3003.
What is Analiese Medero-Gierbolini's NPI number?
Analiese Medero-Gierbolini's National Provider Identifier (NPI) is 1881832152, issued on 01/26/2009.
Does Analiese Medero-Gierbolini prescribe more brand-name or generic drugs?
Analiese Medero-Gierbolini's prescribing is 4% brand-name and 96% generic drugs by claim count, with $2K in brand drug costs.
How many General Practice Physician providers are there in the US?
There are 16,725 General Practice Physician providers across 56 states in the US. The average General Practice Physician provider writes 2,872 Medicare Part D claims per year.
What drugs does Analiese Medero-Gierbolini prescribe most often?
Based on 2023 Medicare Part D data, Analiese Medero-Gierbolini's most frequently prescribed drugs include Famotidine, Azithromycin, Prednisone. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does Analiese Medero-Gierbolini accept Medicare?
Analiese Medero-Gierbolini appears in CMS Medicare data with 384 Part D claims and 224 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify Analiese Medero-Gierbolini's credentials?
Analiese Medero-Gierbolini's NPI is 1881832152. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

View source datasets and methodology notes
Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology

Compiled from official public sources by the PlainDoctor editorial team.